miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5.
Yuan C, Su Z, Liao S, Li D, Zhou Z, Wang Y, Quan M, Zeng L, Lv C, Shen C, Gong W, Wu J, Chen X, Hu W, Lv X, Si W, Yu X.
Yuan C, et al. Among authors: lv x, lv c.
Cancer Cell Int. 2021 Jul 21;21(1):390. doi: 10.1186/s12935-021-02092-7.
Cancer Cell Int. 2021.
PMID: 34289837
Free PMC article.